Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

CUSIP: 67080M103

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
104,555,500
Total 13F shares
84,776,704
Share change
-3,558,941
Total reported value
$783,330,709
Put/Call ratio
11%
Price per share
$9.24
Number of holders
171
Value change
-$36,480,592
Number of buys
82
Number of sells
83

Quarterly Holders Quick Answers

What is CUSIP 67080M103?
CUSIP 67080M103 identifies NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q3 2025

As of 30 Sep 2025, Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) was held by 171 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,776,704 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., Deep Track Capital, LP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Commodore Capital LP, Redmile Group, LLC, Vestal Point Capital, LP, Point72 Asset Management, L.P., and STATE STREET CORP. This page lists 171 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.